Clinical characteristics, species distribution, and antifungal resistance of Candida spp. causing candidemia: A retrospective study at University Medical Center Ho Chi Minh City in 2024

  • Trần Thị Huệ Vân Đại học Y Dược Thành phố Hồ Chí Minh
  • Văn Thị Thanh Thủy Đại học Y Dược Thành phố Hồ Chí Minh

Main Article Content

Keywords

Candidemia, antifungal resistance, Candida spp.

Abstract

To describe the sdistribution of Candida bloodstream infections and antifungal resistance patterns at University Medical Center Ho Chi Minh City in 2024, s retrospective descriptive case-series study was conducted. The results shown that total 7.3% positive for Candida spp are C. albicans (37.7%), C. glabrata (20.8%), C. tropicalis (16.9%), and C. parapsilosis (15.6%). Candidemia mainly occurred in elderly patients with multiple comorbidities, including hypertension (46.8%), type 2 diabetes mellitus (45.5%), and malignancy (33.8%). Major predisposing risk factors for candidemia were present in most patients, including central venous catheterization (81.8%), urinary catheterization (77.9%), parenteral nutrition (77.9%), mechanical ventilation (59.7%), hemodialysis (27.3%), and endotracheal intubation (26.0 The highest antifungal resistance rate was observed for fluconazole (23.1%), followed by voriconazole (9.9%) and amphotericin B (1.4%); no resistance to caspofungin or micafungin was detected. In conclusion Candida spp was the main cause of fungal bloodstream infections (C. albicans, C. glabrata, C. tropicalis, and C. parapsilosis) occurring in elderly patients with multiple comorbidities and major risk factors, including central venous catheterization, urinary catheterization, mechanical ventilation, hemodialysis, and endotracheal intubation. Antifungal resistance among Candida spp were fluconazole, followed by voriconazole and amphotericin B, while no resistance to caspofungin or micafungin was detected.

Article Details

References

1. Phạm Văn Phúc, Lê Thi Huyền, Roãn Thị Hương, Lương Hương Giang (2025) Đặc điểm dịch tễ, lâm sàng và kết quả điều trị ở bệnh nhân nhiễm Candida máu tại Khoa Hồi sức tích cực, Bệnh viện Bệnh nhiệt Đới Trung ương. Tạp chí Y học Việt Nam. 547(3)doi:10.51298/vmj.v547i3.13153
2. Pappas PG, Lionakis MS, Arendrup MC, Ostrosky-Zeichner L, Kullberg BJ (2018) Invasive candidiasis. Nat Rev Dis Primers 4: 18026. doi:10.1038/nrdp.2018.26.
3. Casalini G, Giacomelli A, Antinori S (2024) The WHO fungal priority pathogens list: A crucial reappraisal to review the prioritisation. Lancet Microbe 5(7): 717-724. doi:10.1016/s2666-5247(24)00042-9
4. Lê Thị Diễm, Nguyễn Phú Hương Lan, Nguyễn Thị Hà và cộng sự (2023) Đặc điểm nhiễm candida huyết tại Bệnh viện Bệnh Nhiệt đới. Tạp chí Y học Việt Nam (Tổng hội Y học Việt Nam). tr. 126-132.
5. Mora Carpio AL, Climaco A. Candidemia. StatPearls. 2025.
6. Salmanton-García J, Cornely OA, Stemler J et al (2024) Attributable mortality of candidemia - Results from the ECMM Candida III multinational European Observational Cohort Study. J Infect 89(3):106229. doi:10.1016/j.jinf.2024.106229
7. Won EJ, Choi MJ, Jeong SH et al (2022) Nationwide Surveillance of Antifungal Resistance of Candida Bloodstream Isolates in South Korean Hospitals: Two Year Report from Kor-GLASS. Journal of Fungi 8(10):996. doi:10.3390/jof8100996.